Comparison of final adult height in boys with idiopathic short stature accepted growth hormone treatment or not / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 1019-1021, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-412761
ABSTRACT
Objective In order to understand whether recombinant human growth hormone(r-hGH) can improve the idiopathic short stature(ISS) boys' final adult height(FAH).Methods We measured 16 cases diagnosed as ISS boys FAH, divided into 2 groups, of which 9 cases were not given r-hGH treatment, treatment group ,7 patients received r-hGH treatment, a dose of 0.1 ~ 0.13 U· kg-1·d-1, before going to sleep subcutaneous injection, duration of treatment was 6 ~ 20 months ( 11.9 ± 5.2 months).Results The treatment group compared with the average FAH FAH observation group had significantly improved the average(t =2.219,P<0.05).Conclusion r-hGH can improve the ISS boys FAH, but early treatment, the longer the course the more obvious effects.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Primary Medicine and Pharmacy
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS